30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.

      Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
      Antipsychotic Agents, adverse effects, pharmacokinetics, therapeutic use, Basal Ganglia Diseases, chemically induced, Bipolar Disorder, drug therapy, Body Weight, drug effects, Cognition, Dyskinesia, Drug-Induced, etiology, Electrocardiography, Humans, Lipoproteins, Piperazines, Quinolones, Randomized Controlled Trials as Topic, Schizophrenia

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The discovery of antipsychotic medications has revolutionized the treatment of schizophrenia and other psychotic disorders. However, side effects such as extrapyramidal symptoms (EPS) and tardive dyskinesia (TD), electrocardiogram (ECG) changes, weight gain, and metabolic disturbances indicate the continued need to develop new agents. The introduction of atypical drugs such as clozapine, risperidone, olanzapine, quetiapine, and ziprasidone has widened our choices. This article provides an overview of the pharmacology, efficacy, and techniques for the clinical use of aripiprazole, a novel agent with a unique pharmacological profile.

          Related collections

          Author and article information

          Comments

          Comment on this article